CIAPIN1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

	Compound	Confidence	Supporting neighbours

Clinical trials — most relevant to CIAPIN1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis	PHASE4	RECRUITING
Pharmacogenomic Evaluation of Antihypertensive Responses	PHASE4	COMPLETED
Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential Hypertension	PHASE3	COMPLETED
Sterile Amniotic Fluid Filtrate Epidural Injection.	PHASE1/PHASE2	COMPLETED
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients	PHASE2	COMPLETED
Steroid Treatment After Resuscitated Out-of-Hospital Cardiac Arrest	PHASE2	COMPLETED
First-In-Human Clinical Study of the C3 Complement Inhibitor AMY- 101 in Healthy Male Volunteers	PHASE1	COMPLETED
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms	nan	COMPLETED
Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome	nan	UNKNOWN
The Synergistic Effects of AIH and FES in Persons With MS	nan	ACTIVE_NOT_RECRUITING
Correlation Between Vaspin Gene Polymorphism and Serum Vaspin Levels in Psoriasis Vulgaris	nan	RECRUITING
Relationship of Gestational Age and Urine Concentration of S100B in Preterm and Term Infants in the First Week of Life	nan	COMPLETED
Family Blood Pressure Program - HyperGEN	nan	COMPLETED
Family Blood Pressure Program - GENOA	nan	COMPLETED
Family Blood Pressure Program - SAPPHIRe Network	nan	COMPLETED
p11 Protein Levels in Patients With Major Depressive Disorder Treated With Citalopram	nan	COMPLETED
Assessment of Disease Severity, Progression and Treatment in Infected Patients Presenting to the Emergency Department	nan	COMPLETED
Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular Disease	nan	COMPLETED
The Predictive Role of Urinary Proteomics in Blood Pressure Response of Obese Hypertensive Treated With Irbesartan or Eplerenone.	nan	UNKNOWN
SEXI: Sciatic Expression and Identification of Differential Proteins in Traumatized Versus Nontraumatized Nerves	nan	UNKNOWN
Genetic Response to Warfarin in Healthy Subjects	nan	COMPLETED
Serum Vasohibin, Cardiotrophin, Endocan & Perinatal Outcomes	nan	UNKNOWN
Corpus Callosum Agenesis and Intellectual Disability	nan	COMPLETED
Identification of Novel Molecular Markers for Vasospasm	nan	COMPLETED
Paediatric Obesity and Cardiovascular Dysfunction	nan	COMPLETED
Clubfoot DNA Repository	nan	COMPLETED
Genes of Hypertension in African Americans	nan	COMPLETED
Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia	nan	COMPLETED
Family Blood Pressure Program - GenNet Network	nan	COMPLETED
Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a CIAPIN1 binder may also engage these)

Protein	Name	Similarity
Q5XID1	—	1.000	Q5XID1 →
Q8WTY4	—	1.000	Q8WTY4 →
Q5EAC7	—	1.000	Q5EAC7 →
Q5ZJA2	—	0.998	Q5ZJA2 →
Q4SK88	—	0.997	Q4SK88 →
Q4V7N8	—	0.995	Q4V7N8 →
C0HBG1	—	0.995	C0HBG1 →
C3YFB4	—	0.993	C3YFB4 →
C1BH56	—	0.993	C1BH56 →
A4IHR0	—	0.992	A4IHR0 →
B5XEX1	—	0.992	B5XEX1 →
B4LRY2	—	0.991	B4LRY2 →
B3RVZ1	—	0.991	B3RVZ1 →
B7PP17	—	0.990	B7PP17 →
B4KLC0	—	0.990	B4KLC0 →
Q6AZB3	—	0.989	Q6AZB3 →
A7S710	—	0.989	A7S710 →
B3N5N3	—	0.988	B3N5N3 →
Q9V3Y2	—	0.988	Q9V3Y2 →
B4GK79	—	0.986	B4GK79 →
B3MLC5	—	0.985	B3MLC5 →
B4Q5Z1	—	0.985	B4Q5Z1 →
Q7PWQ6	—	0.984	Q7PWQ6 →
Q29P70	—	0.984	Q29P70 →
B4HXL7	—	0.984	B4HXL7 →
Q7XPW7	—	0.984	Q7XPW7 →
B4JAX0	—	0.984	B4JAX0 →
B0WQ75	—	0.984	B0WQ75 →
A1CQP0	—	0.983	A1CQP0 →
B4NYT3	—	0.983	B4NYT3 →